CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
ppublish
Résumé
Solid tumors, especially those with aberrant MYCN activation, often harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance. Despite this knowledge, there are no effective strategies to tackle this problem. We found that chemokine-like factor (
Identifiants
pubmed: 38489372
doi: 10.1126/sciadv.adh9547
pmc: PMC10942121
doi:
Substances chimiques
N-Myc Proto-Oncogene Protein
0
MYCN protein, human
0
CKLF protein, human
0
Chemokines
0
MARVEL Domain-Containing Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadh9547Références
Cancer Cell. 2012 Mar 20;21(3):362-73
pubmed: 22439933
J Exp Med. 2017 Dec 4;214(12):3519-3530
pubmed: 29066577
Cancer Cell. 2017 Sep 11;32(3):310-323.e5
pubmed: 28867147
Nat Genet. 2018 Apr;50(4):515-523
pubmed: 29379199
Cancer Res. 2017 Feb 15;77(4):971-981
pubmed: 27923830
Adv Cancer Res. 2010;107:163-224
pubmed: 20399964
Cancer Res. 2021 Oct 1;81(19):5047-5059
pubmed: 34301764
Eur J Immunol. 2019 Aug;49(8):1140-1146
pubmed: 31257581
Cancer Discov. 2018 Mar;8(3):320-335
pubmed: 29284669
Cancer Cell. 2012 Nov 13;22(5):631-44
pubmed: 23153536
Genome Biol. 2015 Jun 25;16:133
pubmed: 26109056
Arch Pathol Lab Med. 2017 Jun;141(6):751-758
pubmed: 28557599
Oncoimmunology. 2017 Apr 28;6(6):e1320626
pubmed: 28680756
Clin Cancer Res. 2016 Apr 15;22(8):1865-74
pubmed: 27084740
Nat Protoc. 2006;1(3):1133-9
pubmed: 17406394
Int J Cancer. 2008 Feb 1;122(3):699-704
pubmed: 17943719
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Sci Rep. 2022 Feb 23;12(1):3069
pubmed: 35197510
Clin Cancer Res. 2018 Nov 15;24(22):5673-5684
pubmed: 29784674
Cancer Immunol Immunother. 2019 Dec;68(12):1935-1947
pubmed: 31641795
Science. 1984 Jun 8;224(4653):1121-4
pubmed: 6719137
Oncogene. 2017 Jul 6;36(27):3852-3867
pubmed: 28263972
Cancer Discov. 2018 Feb;8(2):150-163
pubmed: 29358508
Dev Comp Immunol. 2015 Sep;52(1):75-80
pubmed: 25917429
Cancer Cell. 2012 Jul 10;22(1):117-30
pubmed: 22789543
Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386
pubmed: 28142287
Geroscience. 2023 Jun;45(3):1889-1898
pubmed: 36856946
Mod Pathol. 2020 Apr;33(4):531-540
pubmed: 31695155
Cancer Res. 2012 May 1;72(9):2162-71
pubmed: 22549946
Cell Rep. 2017 Jul 18;20(3):558-571
pubmed: 28723561
Genome Biol. 2008 Oct 13;9(10):R150
pubmed: 18851746
Oncogene. 1996 Aug 15;13(4):803-12
pubmed: 8761302
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
pubmed: 16617117
J Clin Oncol. 2015 Sep 20;33(27):3008-17
pubmed: 26304901
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1229-E1238
pubmed: 29374092
Nat Immunol. 2021 May;22(5):607-619
pubmed: 33833438
N Engl J Med. 1985 Oct 31;313(18):1111-6
pubmed: 4047115
Front Oncol. 2021 Feb 03;10:625332
pubmed: 33614505
Immunity. 2020 Jan 14;52(1):17-35
pubmed: 31940268
J Exp Med. 2005 Oct 3;202(7):919-29
pubmed: 16186184
Ann N Y Acad Sci. 2015 Jan;1335:23-31
pubmed: 25315505
Blood. 2011 Jan 27;117(4):e49-56
pubmed: 21084707
Gastroenterology. 2021 Feb;160(3):690-709
pubmed: 33279516
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19190-5
pubmed: 23091029
J Immunol. 2016 Nov 1;197(9):3520-3530
pubmed: 27694495
Cancer Gene Ther. 2022 Jan;29(1):10-21
pubmed: 33603130
Clin Immunol. 2020 Aug;217:108510
pubmed: 32544611
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Genet Genomics. 2020 Sep 20;47(9):547-561
pubmed: 33309050
Front Immunol. 2017 Nov 03;8:1473
pubmed: 29163537
BMC Dev Biol. 2007 May 04;7:42
pubmed: 17477879
J Clin Med. 2022 Feb 11;11(4):
pubmed: 35207219
Dev Comp Immunol. 2009 Apr;33(4):646-52
pubmed: 19073209
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Dev Comp Immunol. 2011 Jun;35(6):650-60
pubmed: 21272597
Immunity. 2022 Jul 12;55(7):1173-1184.e7
pubmed: 35700740
Front Cell Dev Biol. 2021 May 20;9:660969
pubmed: 34095125
J Clin Invest. 2007 Sep;117(9):2702-12
pubmed: 17710228
Cancer Cell Int. 2017 Mar 31;17:43
pubmed: 28367105
Lancet. 2007 Jun 23;369(9579):2106-20
pubmed: 17586306
Histopathology. 2015 Sep;67(3):368-77
pubmed: 25641082
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Comput Struct Biotechnol J. 2021 Jul 18;19:4101-4109
pubmed: 34527184
Int J Biochem Cell Biol. 2008;40(5):909-19
pubmed: 18069042
Cell Death Dis. 2013 Apr 11;4:e586
pubmed: 23579273
Immunity. 2019 Feb 19;50(2):302-316
pubmed: 30784578
Methods Mol Biol. 2009;546:117-30
pubmed: 19378101
Cancer Res. 2012 Dec 15;72(24):6325-32
pubmed: 23222302
J Immunother Cancer. 2020 Nov;8(2):
pubmed: 33243932
MedComm (2020). 2023 Aug 26;4(5):e343
pubmed: 37638340
Nature. 2022 May;605(7910):532-538
pubmed: 35508657
Cancer Res. 2021 Sep 1;81(17):4417-4430
pubmed: 34233924
Cardiovasc Res. 2008 May 1;78(2):250-6
pubmed: 18252760
Cancers (Basel). 2020 Jul 25;12(8):
pubmed: 32722460
Cancers (Basel). 2021 Nov 04;13(21):
pubmed: 34771703
Gastroenterology. 2008 Jul;135(1):234-43
pubmed: 18485901
Genome Biol. 2014 Dec 03;15(12):523
pubmed: 25633159
Genes (Basel). 2017 Mar 30;8(4):
pubmed: 28358317
J Immunother Cancer. 2021 Feb;9(2):
pubmed: 33589525
N Engl J Med. 2010 Jun 10;362(23):2202-11
pubmed: 20558371
J Immunother Cancer. 2021 May;9(5):
pubmed: 34016720
Children (Basel). 2019 Jan 17;6(1):
pubmed: 30658459